March, 2009Repeated Use of General Anesthesia in Kids Linked to Learning Disabilities
Young children who have undergone multiple surgeries under general anesthesia appear to be at greater risk of developing learning disabilities later in life, new medical research shows. Scientists at the Mayo Clinic in Rochester, Minn. found that children who had two or more surgeries involving the use of general anesthesia before age four were more than twice as likely to develop attention-deficit disorder, problems with reading, writing, and other learning disabilities. The increased risk of learning disabilities in children was …
Continue →Consumer Groups Call for Senior FDA Official to Oversee Food Safety; Larger Overhaul May Be on the Way
Two consumer advocacy groups are calling on President Barack Obama to appoint a senior food safety official to temporarily take charge of the Food and Drug Administration’s oversight of the nation’s food supply.
Continue →Massive Wal-Mart Sex Discrimination Class-Action Suit Facing New Legal Challenge
A huge, nationwide class-action lawsuit filed on behalf of about two million women who are former or current employees of retail giant Wal-Mart is facing a new legal challenge.
Continue →Former Morgan Stanley Supervisor Convicted of Securities Fraud
A former Morgan Stanley Co. supervisor has been convicted of securities fraud for his role in a scheme involving kickbacks paid by the stock-loan industry. Darren DeMizio was found guilty by a New York jury and faces up to 25 years in prison. He is the latest in a string of dozens of securities traders from numerous Wall Street firms who have admitted accepting millions of dollars in kickbacks from stock-loan “finders.” Stock-loan finders are commonly used by securities firms …
Continue →Propafenone HCl Tablets
Audience: Cardiology healthcare professionals, patients [Posted 03/25/2009] FDA and Watson Pharmaceuticals notified healthcare professionals and patients of a recall of Propafenone HCl 225 mg tablets, a drug product used to treat cardiac…
Acai Berry Scams Targeted; Connecticut AG Launches Probe into Weight-Loss Claims
Bold promises of weight loss, improved health, and detoxification from products containing the acai berry should be treated with caution, especially when “free trial offers” of the products extended over the Internet require consumers to provide their credit card information, a nonprofit health watchdog group said.
Continue →FDA Approves Symbyax For Treatment-Resistant Depression
Symbyax, an Eli Lilly drug which combines the top-selling antipsychotic drug Zyprexa and the leading antidepressant Prozac, has been approved by the Food and Drug Administration for patients with treatment-resistant depression. People who suffer from depression and have failed to respond to treatment with at least two regular antidepressants are said to have treatment-resistant depression. The FDA has previously delayed approvals for Symbyax and required Lilly to gather more data about the drug. Symbyax is billed by its maker as …
Continue →Thinning of Brain Key to Detecting Risk of Depression, Researchers Find; Preventative Care of Depression May Be Improved
People who are at increased risk of developing depression due to a family history of the condition have less brain matter on the right cortex of their brains, a thinning of brain matter that is similar to what is seen in Alzheimer’s patients, new medical research indicates.
Continue →Aggressively Controlling Blood Sugar Levels May Be Killing ICU Patients, Researchers Say
Aggressively lowering glycemia, or high blood sugar, in people who are being treated in hospital intensive care units may be killing some patients, new research shows. People who become acutely ill and also have high blood sugar levels tend to do worse than others, but now the common practice of using medication to dramatically lower blood sugar in urgently hospitalized people in an effort to improve their treatment has been linked to problems. Medicating patients to bring down their blood …
Continue →Oversized Heart Pills Recalled Due to Possible Double Doses
Tablets of Propafenone HCL, a Watson Pharmaceuticals Inc. drug used to treat irregular heartbeats, have been recalled due to concerns the oversized pills may contain dangerous double doses of the active ingredient. The recall involves one lot of the 225 mg tablets sold in 100-count bottles across the United States. The pills were shipped to customers between October 15, 2008 and November 26, 2008. Patients who take Propafenone HCL tablets are encouraged to check their bottle for the lot number …
Continue →Recent Related Features
All Stories
facebook
rss
twitter